Pelthos Therapeutics, Inc. (PTHS)
28.48
-2.52
(-8.13%)
USD |
NYAM |
Jan 02, 12:14
Pelthos Therapeutics Total Liabilities (Quarterly): 68.18M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 526.60M |
| Agenus, Inc. | 514.76M |
| Travere Therapeutics, Inc. | 465.02M |
| Inhibrx Biosciences, Inc. | 140.64M |
| Palvella Therapeutics, Inc. | 28.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.43M |
| Shareholders Equity (Quarterly) | 58.25M |
| Debt to Equity Ratio | 0.0597 |
| Current Ratio | 1.980 |
| Net Debt Paydown Yield | -3.77% |